MR screening moves into CT void

Article

Some walk-in CT clinics in the U.S. may be closing their doors, but the concept of consumer-led preventive imaging is far from dead, particularly in Asia. Interest there is switching to MR as a screening tool to reassure "the worried well" and reveal dormant disease.

During the last four years, for example, more than 4000 people have undergone a whole-body MR exam at the Imaging Center at Veterans General Hospital (VGH) in Taipei, Taiwan. Self-referrals account for most whole-body MR exams, which are available to anyone who can pay ($US1000 for complete tumor survey and another $US1000 for neurovascular or cardiac assessment).

Charles H. Cheng, Ph.D., an attending physician in the VGH radiology department, acknowledges that the screening program will attract criticism, but he insists that the whole-body scans will do more good than harm.

"Many people from countries that have comprehensive primary healthcare systems misunderstand what we are doing. They do not realize that what works in Asia is sometimes different from what works elsewhere," Cheng said at the 2004 Asian and Oceanian Congress of Radiology.

Recent Videos
Improving Access to Nuclear Imaging: An Interview with SNMMI President Jean-Luc C. Urbain, MD, PhD
SNMMI: 18F-Piflufolastat PSMA PET/CT Offers High PPV for Local PCa Recurrence Regardless of PSA Level
SNMMI: NIH Researcher Discusses Potential of 18F-Fluciclovine for Multiple Myeloma Detection
SNMMI: What Tau PET Findings May Reveal About Modifiable Factors for Alzheimer’s Disease
Emerging Insights on the Use of FES PET for Women with Lobular Breast Cancer
Can Generative AI Reinvent Radiology Reporting?: An Interview with Samir Abboud, MD
Mammography Study Reveals Over Sixfold Higher Risk of Advanced Cancer Presentation with Symptom-Detected Cancers
Combining Advances in Computed Tomography Angiography with AI to Enhance Preventive Care
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
What New Research Reveals About the Impact of AI and DBT Screening: An Interview with Manisha Bahl, MD
Related Content
© 2025 MJH Life Sciences

All rights reserved.